Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
J Psychiatr Res ; 81: 23-35, 2016 10.
Artículo en Inglés | MEDLINE | ID: mdl-27367209

RESUMEN

Recent studies have shown benefits for the supplementation of folic acid in schizophrenic patients. The aim of this study was to evaluate the effects of folic acid addition on adult rats, over a period of 7 or 14 days. It also sets out to verify any potential protective action using an animal model of schizophrenia induced by ketamine, in behavioral and biochemical parameters. This study used two protocols (acute and chronic) for the administration of ketamine at a dose of 25 mg/kg (i.p.). The folic acid was given by oral route in doses of 5, 10 and 50 mg/kg, once daily, for 7 and/or 14 days in order to compare the protective effects of folic acid. Thirty minutes after the last administration of ketamine, the locomotor and social interaction activities were evaluated, and immediately the brain structure were removed for biochemical analysis. In this study, ketamine was administered in a single dose or in doses over the course of 7 days increasing the animal's locomotion. This study showed that the administration of folic acid over 7 days was unable to prevent hyper locomotion. In contrast, folic acid (10 and 50 mg/kg) administrated over a period of 14 days, was able to partially prevent the hyper locomotion. Our data indicates that both acute and chronic administrations of ketamine increased the time to first contact between the animals, while the increased latency for social contact was completely prevented by folic acid (5, 10 and 50 mg/kg). Chronic and acute administrations of ketamine also increased lipid peroxidation and protein carbonylation in brain. Folic acid (10 and 50 mg/kg) supplements showed protective effects on the oxidative damage found in the different brain structures evaluated. All together, the results indicate that nutritional supplementation with folic acid provides promising results in an animal model of schizophrenia induced by ketamine.


Asunto(s)
Déficit de la Atención y Trastornos de Conducta Disruptiva/tratamiento farmacológico , Déficit de la Atención y Trastornos de Conducta Disruptiva/etiología , Ácido Fólico/uso terapéutico , Estrés Oxidativo/efectos de los fármacos , Esquizofrenia/complicaciones , Complejo Vitamínico B/uso terapéutico , Animales , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Antagonistas de Aminoácidos Excitadores/toxicidad , Relaciones Interpersonales , Ketamina/toxicidad , Metabolismo de los Lípidos/efectos de los fármacos , Locomoción/efectos de los fármacos , Masculino , Malondialdehído/metabolismo , Carbonilación Proteica/efectos de los fármacos , Ratas , Ratas Wistar , Esquizofrenia/inducido químicamente , Superóxido Dismutasa/metabolismo , Factores de Tiempo
3.
Dement Geriatr Cogn Disord ; 30(6): 540-6, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-21252549

RESUMEN

AIM: This study explores the effects of a weekly structured music therapy and activity program (MAP) on behavioral and depressive symptoms in persons with dementia (PWD) in a naturalistic setting. METHODS: PWD attended a weekly group MAP conducted by a qualified music therapist and occupational therapist for 8 weeks. Two validated scales, the Apparent Emotion Scale (AES) and the Revised Memory and Behavioral Problems Checklist (RMBPC), were used to measure change in outcomes of mood and behavior. RESULTS: Twenty-eight subjects completed the intervention, while 15 wait-list subjects served as controls. Baseline AES and RMBPC scores were not significantly different between the intervention and control groups. After intervention, RMBPC scores improved significantly (p = 0.006) with 95% CI of the difference between the mean intervention and control group scores compared to baseline at -62.1 to -11.20. Total RMBPC scores in the intervention group improved from 75.3 to 54.5, but worsened in the control group, increasing from 62.3 to 78.6. AES scores showed a nonsignificant trend towards improvement in the intervention group. CONCLUSION: The results suggest that a weekly MAP can ameliorate behavioral and depressive symptoms in PWD.


Asunto(s)
Déficit de la Atención y Trastornos de Conducta Disruptiva/psicología , Déficit de la Atención y Trastornos de Conducta Disruptiva/terapia , Demencia/psicología , Demencia/terapia , Trastorno Depresivo/psicología , Trastorno Depresivo/terapia , Musicoterapia , Anciano , Déficit de la Atención y Trastornos de Conducta Disruptiva/etiología , Cuidadores/psicología , Costo de Enfermedad , Demencia/complicaciones , Trastorno Depresivo/etiología , Manual Diagnóstico y Estadístico de los Trastornos Mentales , Emociones/fisiología , Femenino , Humanos , Masculino , Pruebas Neuropsicológicas , Singapur , Resultado del Tratamiento
5.
J Pediatr ; 147(5): 632-9, 2005 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-16291354

RESUMEN

OBJECTIVE: To determine the efficacy of iron and zinc supplementation on behavior ratings of lead-exposed children. STUDY DESIGN: In this double-blind, randomized trial, 602 first-grade children received 30 mg ferrous fumarate, 30 mg zinc oxide, both, or placebo daily for 6 months. Lead, iron, and zinc status were determined at baseline and follow-up. Parents and teachers provided ratings of child behavior using the Conners Rating Scales. RESULTS: The baseline mean (SD) blood lead concentration was 11.5 (6.1) mug/dL, with 51% of children > or = 10 microg/dL. The prevalence of attention deficit hyperactivity disorder, estimated by combined parent and teacher ratings, was 6%. At follow-up, parent ratings of oppositional, hyperactive, cognitive problems, and attention deficit hyperactivity disorder decreased by 1.5, 1.2, 2.5, and 3.4 points, respectively (P < .05). Teacher ratings of hyperactivity increased by 1.1 points (P = .008), and the mean cognitive problem score declined by 0.7 points (P = .038). There were no treatment effects on mean change in scores, but children receiving any zinc had a higher likelihood of no longer receiving clinically-significant teacher ratings of oppositional behaviors. CONCLUSIONS: This regimen of supplementation did not result in consistent improvements in ratings of behavior in lead-exposed children over 6 months.


Asunto(s)
Déficit de la Atención y Trastornos de Conducta Disruptiva/prevención & control , Exposición a Riesgos Ambientales/efectos adversos , Hierro/uso terapéutico , Plomo/sangre , Zinc/uso terapéutico , Déficit de la Atención y Trastornos de Conducta Disruptiva/epidemiología , Déficit de la Atención y Trastornos de Conducta Disruptiva/etiología , Niño , Método Doble Ciego , Quimioterapia Combinada , Femenino , Humanos , Hierro/administración & dosificación , Deficiencias de Hierro , Plomo/efectos adversos , Modelos Lineales , Modelos Logísticos , Masculino , México/epidemiología , Zinc/administración & dosificación , Zinc/deficiencia
6.
Res Dev Disabil ; 22(6): 449-62, 2001.
Artículo en Inglés | MEDLINE | ID: mdl-11768670

RESUMEN

This study examined the effects of progressive relaxation training on the disruptive behaviors of a boy with autism. Moreover, his overt relaxed behaviors before and after relaxation training were measured using the Behavioral Relaxation Scale (Poppen, 1988, Poppen, 1998). After the participant received training in progressive relaxation procedures a multielement design with three conditions was utilized to determine the effects of the procedures on the duration of the boy's disruptive behaviors during leisure activity sessions. The conditions were: (a) relaxation prior to a leisure activity session; (b) cued relaxation; and (c) no relaxation prior to the session, which represented a baseline condition. Results indicated that the participant acquired progressive relaxation skills, displayed more relaxed behaviors after performing the procedures, and showed a decrease in the duration of his disruptive behaviors upon completing progressive relaxation training prior to a leisure activity session. Implications for future research are discussed.


Asunto(s)
Déficit de la Atención y Trastornos de Conducta Disruptiva/terapia , Trastorno Autístico/complicaciones , Terapia por Relajación , Déficit de la Atención y Trastornos de Conducta Disruptiva/etiología , Déficit de la Atención y Trastornos de Conducta Disruptiva/psicología , Trastorno Autístico/terapia , Niño , Humanos , Masculino , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA